|
|
 |
|
 
| |
|
| ISIN: |
DE0005880405 |
| SCN: |
588040 |
| Trading segment: |
General Standard |
| Stock exchange: |
Frankfurt |
| Financial syndicate: |
Lead-managed:
Sal. Oppenheim jr. & Cie KGaA |
| Stock exchange identifier: |
Gir |
| First quotation: |
May 16, 2000 |
| Subscription price: |
20 EUR |
| Nominal value: |
1 EUR |
| Shareholder structure |
| Solvay Organics GmbH: | | 75% |
| Free-float: | | 25% |
|
| Capital stock after flotation: |
6.50 Mill. EUR |
| End of the business year: |
31st of December |
| Vorstand: |
| Finance & Accouting: | | Martin Weiland |
| Legal Affairs and HR: | | Dr. jur. Harald Mothes |
| Technical Operations, R&D: | | Dr. Hans Hiller |
|
| Supervisory board: |
| Chairman: | | Dr. Frank Schneider |
| Deputy Chairman: | | Dr. Karl-Heinz Köppinger |
| Member: | | Dr. Ernest Alderson Edmonds |
|
| Address: |
Girindus AG
Buchenallee 20
51402 Bensberg, Germany |
| Internet: |
www.girindus.com |
| Contact: |
Ralf Penner
Telefon: +49 2204 92690
Telefax: +49 2204 926990
eMail: rpenner@girindus.com |
|
2007
Mill. EUR |
2006
Mill. EUR |
2005
Mill. EUR |
| Net Sales |
21,8 |
21,6 |
29,4 |
| INVESTITIONEN IN ANLAGEVERMÖGEN |
3,2 |
4,2 |
2,4 |
| ABSCHREIBUNGEN |
2,4 |
2,2 |
2,7 |
| EBITDA |
6,9 |
-5,6 |
-4,1 |
| EBIT |
4,5 |
-7,8 |
-6,8 |
| Earnings per share |
0.27 EUR |
-1.31 EUR |
-1.16 EUR |
| Stockholders' equity as of Dec. 31 |
11,1 |
10,0 |
19,1 |
| Equity to assets (%) |
36,7 |
28.8 |
56.7 |
| Fixed assets as of Dec. 31 |
19,8 |
20,0 |
18,7 |
| Current assets as of Dec. 31 |
10,6 |
12,5 |
12,5 |
| Number of employees as of Dec. 31 |
150 |
159 |
164 |
back to top
|
|
|
|
|
|
